Friday, October 15, 2021

BioMarin’s CEO Bienaime, in his 16th year at the helm, scores $18M pay package


How’s this for a resume nugget?

In each of Jean-Jacques Bienaime’s 16 years as CEO at BioMarin, the California biotech has reported a revenue increase as it has worked to advance therapies against rare genetic diseases.

As a result, Bienaime has been amply compensated. Still, the company faced a big setback last year with the FDA’s rejection for a gene therapy candidate for hemophilia. 

Last year, Bienaime collected $18.12 million in total pay, with $15.06 million coming by way of equity awards on top of his $1.30 million salary, the biotech said in a proxy statement. He also pulled down $1.66 million in incentive performance cash.

Bienaime’s package didn’t quite measure up to the $18.41 million he received in 2019. The difference can be attributed to his incentive performance cash pay, which totaled $2.32 million during the prior year.  

RELATED: Top 10 takeover targets in biopharma: 3. BioMarin Pharmaceutical

BioMarin’s other executives fared well in 2020, led by R&D chief Henry Fuchs, M.D., who collected $7.46 million in total pay. CFO Brian Mueller pulled down $5.84 million, while CCO Jeff Ajer netted $4.54 million in compensation.  

While BioMarin continued its progress on its rare-disease strategy last year, the company hit a setback in August when the FDA rejected its promising candidate valrox. Before the rejection, the drug appeared ready to become the first gene therapy for hemophilia.

RELATED: FDA gets out its red pen again, rejecting BioMarin’s rejecting its gene therapy valrox amid durability worries

While BioMarin goes back to work on valrox, it’s bottom-line success is ensured by drugs such as Vimizim for metabolic disorders and two treatments for phenylalanine, a rare condition which causes the build up of amino acids. The drugs are Kuvan and the fast-rising Palyniq. Kuvan sales are on the slide now thanks to generic competition in the U.S.



Source link

Latest Articles

Widely used chemical linked to 1,00,000 US deaths per year: Study

NEW YORK: Daily exposure to phthalates, a group of chemicals used in everything from plastic containers to makeup, may lead to approximately 100,000 deaths...

Foods to Reduce Inflammation and Strengthen the Immune System

Did you know that you can greatly reduce inflammation and boost your immune system by simply incorporating more anti-inflammatory foods and beverages into your...

Personal Selling

INTRODUCTION Early sellers and traders were not held in high esteem. The Roman word for salesman meant ‘Cheater’ and...

Building Muscle on a Vegan Diet

There are a lot of  misconceptions surrounding veganism. The notion that those who practice it are lacking in protein and therefore muscles is the...

Electrodes in brain new hope for severe cases of epilepsy

Neurosurgeons at All India Institute of Medical Sciences have devised a new technique for operating on children suffering from a severe form of epilepsy...